Sale

Autotransfusion Devices Market

Global Autotransfusion Devices Market Share, Size, Analysis, Growth: By Product Type: Autotransfusion Systems, Consumables, and Accessories; By Application: Cardiovascular Surgeries, Orthopaedic Surgeries, Neurological Surgeries, Organ Transplantation, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Autotransfusion Devices Market Outlook

The global autotransfusion devices market size attained a value of USD 297.26 million in 2023, driven by developing healthcare infrastructure, rapid diagnosis of diseases, rising incidences of haemorrhage, increasing need for safe and sufficient medical procedures, availability of different types of autotransfusion systems and their exceptional benefits. The market is anticipated to grow at a CAGR of 5.0% during the forecast period of 2024-2032 to attain a value of USD 461.14 million by 2032.

 

autotransfusion-devices-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Demand for Intraoperative Autotransfusion Systems to Propel the Market Growth of Autotransfusion Devices

Based on product type, the demand for intraoperative transfusion systems is witnessing a healthy growth. The intraoperative autotransfusion systems enable the collection of a patient's own blood during a surgery or an invasive procedure where the blood loss can be anticipated or unpredictable. The washed red blood cells are then transfused back to the patient’s body after the removal of discarded products like platelets and anticoagulants. It decreases net perioperative blood loss, helps maintain postoperative haemoglobin, reduces the risk of blood-borne diseases, reduces patient care costs, eliminates the risk of receiving wrong blood due to human or clerical error, and helps recycle lost blood products. Moreover, the patient's own fresh red blood cells are known to maintain their flexibility in the microcirculation, thereby becoming immediately active in tissue oxygenation. The government initiatives towards developing national frameworks that would maximise patient safety during intraoperative autotransfusion are likely to bolster the autotransfusion devices market growth over the forecast period.

 

Market Segmentation

Autotransfusion devices refer to equipment that helps in the autotransfusion of blood, including the offering of autologous blood to a patient during surgical or invasive procedures. The autologous blood is collected from a patient during heavy blood loss, and the washed red blood cells are re-infused into the body. The autotransfusion of blood is safe, cost-effective, and reduces the dependency on allogenic blood.

 

autotransfusion-devices-market-by-segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market for autotransfusion devices, by product type, is divided into:

  • Autotransfusion Systems
    • Intraoperative Autotransfusion Systems
    • Post-Operative Autotransfusion Systems
    • Dual-Mode Autotransfusion Systems
  • Consumables and Accessories

Based on application, the market is segmented into:

  • Cardiovascular Surgeries
  • Orthopaedic Surgeries
  • Neurological Surgeries
  • Obstetrics and Gynaecology Surgeries
  • Others

On the basis of end-use, the market is classified into:

  • Hospitals
  • Speciality Clinics
  • Others

The regional markets for autotransfusion devices can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

autotransfusion-devices-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Surgeries and the Exceptional Benefits of the Devices to Drive the Market Growth of Autotransfusion Devices

The increasing number of surgeries conducted worldwide, owing to the developing healthcare infrastructure and the rapid diagnosis of diseases, leads to the increased demand for blood for performing these procedures, which is driving the autotransfusion devices market growth. The rising incidences of haemorrhage and the increasing need for safe and sufficient blood and blood products to save lives are propelling the demand for these devices. The autotransfusion of blood offers multiple advantages over donated blood, such as it is cost-effective, does not lose its fluidity and function during storage, reduces the risk of infections and complications, eliminates the dependency on blood bank reserves, and reduces morbidity rate. Additionally, it is considered a safe procedure, owing to the advancements in filtration and sterile techniques. The availability of different types of autotransfusion systems, such as in-line, self-filling, and continuous, is aiding the market development. Continuous autotransfusion is faster, requires less staffing involvement, and poses a reduced risk of contamination. The strong presence of autotransfusion device manufacturers and their initiatives to launch sophisticated, effective, and automated devices are expected to augment the market growth over the forecast period.

 

Key Players in the Global Market for Autotransfusion Devices

The report gives a detailed analysis of the following key players in the global autotransfusion devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • LivaNova PLC
  • Haemonetics Corporation
  • Medtronic plc
  • Fresenius SE & Co. KGaA
  • Becton, Dickinson, and Company (BD)
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • End User
  • Region
Breakup by Product Type
  • Autotransfusion System
  • Consumables and Accessories
Breakup by Application
  • Cardiovascular Surgeries
  • Orthopaedic Surgeries
  • Neurological Surgeries
  • Organ Transplantation
  • Obstetrics and Gynaecological Surgeries
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • LivaNova PLC
  • Haemonetics Corporation
  • Medtronic plc
  • Fresenius SE & Co. KGaA
  • Becton, Dickinson, and Company (BD)
  • Redax
  • Braile Biomedica
  • Gen world Medical Devices
  • SARSTEDT AG & CO. Kg
  • Teleflex Incorporated
  • Zimmer Biomet Holdings Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Autotransfusion Devices Market Overview 

    3.1    Global Autotransfusion Devices Market Historical Value (2017-2023)
    3.2    Global Autotransfusion Devices Market Forecast Value (2024-2032)
4    Global Autotransfusion Devices Market Landscape
    4.1    Global Autotransfusion Devices Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Autotransfusion Devices Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Application
        4.2.3    Analysis by End User
5    Global Autotransfusion Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Autotransfusion Devices Market Segmentation 
    6.1    Global Autotransfusion Devices Market by Product Type
        6.1.1    Market Overview
        6.1.2    Autotransfusion System
            6.1.2.1    Intraoperative Autotransfusion System
            6.1.2.2    Post-Operative Autotransfusion System
            6.1.2.3    Dual-Mode Autotransfusion Systems
        6.1.3    Consumables and Accessories
    6.2    Global Autotransfusion Devices Market by Application
        6.2.1    Market Overview
        6.2.2    Cardiovascular Surgeries
        6.2.3    Orthopaedic Surgeries
        6.2.4    Neurological Surgeries
        6.2.5    Organ Transplantation
        6.2.6    Obstetrics and Gynaecological Surgeries
        6.2.7    Others
    6.3    Global Autotransfusion Devices Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Specialty Clinics
        6.3.4    Others
    6.4    Global Autotransfusion Devices Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Autotransfusion Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Autotransfusion Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Autotransfusion Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Autotransfusion Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Autotransfusion Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1     LivaNova PLC
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Haemonetics Corporation
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Medtronic plc
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Fresenius SE & Co. KGaA
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Becton, Dickinson, and Company (BD)
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Redax 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Braile Biomedica
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Gen world Medical Devices
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    SARSTEDT AG & CO. Kg
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Teleflex Incorporated
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Zimmer Biomet Holdings Inc.
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
18    Global Autotransfusion Devices Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market Autotransfusion Devices attained a value of USD 297.26 million.

The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to reach a value of USD 461.14 million by 2032.

The major market drivers include the developing healthcare infrastructure, rapid diagnosis of diseases, rising incidences of haemorrhage, increasing need for safe and sufficient medical procedures, availability of different types of autotransfusion systems and their exceptional benefits, need to reduce the dependency on blood bank reserves, and government initiatives to maximise patient safety during intraoperative autotransfusion of blood.

The key trends guiding the growth of the market include the rising number of surgeries worldwide, development of efficient and automated autotransfusion devices, and the increasing penetration of market players in emerging nations.

The major regions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The significant product types of autotransfusion devices include autotransfusion systems, and consumables and accessories.

The different applications of autotransfusion devices include cardiovascular surgeries, orthopaedic surgeries, neurological surgeries, and obstetrics and gynaecology surgeries, among others.

The major end uses of autotransfusion devices include hospitals, and speciality clinics, among others.

The major players in the market are LivaNova PLC, Haemonetics Corporation, Medtronic plc, Fresenius SE & Co. KGaA, and Becton, Dickinson, and Company (BD), among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER